Cancer Research  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 2126-2133, May 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, J.-D.
Right arrow Articles by Bekesi, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, J.-D.
Right arrow Articles by Bekesi, J. G.

Inhibition of Microtubule Assembly in Tumor Cells by 3-Bromoacetylamino Benzoylurea, a New Cancericidal Compound1

Jian-Dong Jiang, Yue Wang, John Roboz, James Strauchen, James F. Holland and J. George Bekesi2

Division of Neoplastic Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029

We have synthesized a new compound, 3-bromoacetylamino benzoylurea (3-BAABU), which showed strong cancericidal activity by inducing irreversible mitotic arrest and subsequently apoptosis in human T cell leukemic cells (CEM), human biphenotypic leukemic cells (SP), a human prostate cancer cell line (PC-3), murine melanoma cells (B-16), and murine lymphoma/leukemia cells (EL4) in vitro with an ID50 in the range of 0.013–0.07 µg/ml (0.04–0.22 µM). Treatment of tumor cells for 12–24 h with 3-BAABU resulted in mitotic arrest at prometaphase/metaphase/anaphase, with separation and dispersion of chromosomes and with the absence of mitotic spindle apparatus in cytoplasm. Treatment with 3-BAABU had no cytotoxic and mitotic blocking effect in normal human lymphocytes, proliferating fibroblast cells (3T3), or proliferating myocardial cells (MOT). Cell cycle analyses showed that most treated leukemic cells accumulated at M phase 12 h after treatment. By the end of 48 h of treatment, the cells underwent apoptosis with DNA fragmentation. 3-BAABU inhibited the assembly of microtubules from tubulin but did not interfere with the disassembly of microtubules. The presence and the position of bromine and urea groups on the benzoic ring are the determining factors for its inhibition of microtubule assembly. Replacing bromine with chlorine yielded much less mitotic blocking activity and increased the ID50 40-fold. Substitution of the urea group with ethyl ester abrogated the activity of blocking mitosis but induced apoptosis. Moving the bromoacetylamino group from the 3-position to the 4-position removed blocking activity for mitosis but induced necrosis. These results suggest that 3-BAABU possesses a unique and functional structure and is a potential agent for cancer chemotherapy.

1 This work was supported by the T. J. Martell Memorial Foundation for Leukemia, Cancer and AIDS Research.

2 To whom requests for reprints should be addressed, at Mount Sinai School of Medicine, Box 1131, One Gustave Levy Place, New York, NY 10029. Phone: (212) 241-8245; Fax: (212) 996-9801.

Received 10/ 1/97. Accepted 3/16/98.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Y.-M. Wang, L.-X. Hu, Z.-M. Liu, X.-F. You, S.-H. Zhang, J.-R. Qu, Z.-R. Li, Y. Li, W.-J. Kong, H.-W. He, et al.
N-(2,6-Dimethoxypyridine-3-yl)-9-Methylcarbazole-3-Sulfonamide as a Novel Tubulin Ligand against Human Cancer
Clin. Cancer Res., October 1, 2008; 14(19): 6218 - 6227.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. Mulligan, L. M. Greene, S. Cloonan, M. M. Mc Gee, V. Onnis, G. Campiani, C. Fattorusso, M. Lawler, D. C. Williams, and D. M. Zisterer
Identification of Tubulin as the Molecular Target of Proapoptotic Pyrrolo-1,5-benzoxazepines
Mol. Pharmacol., July 1, 2006; 70(1): 60 - 70.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
C.-C. Ho, S.-S. Lin, M.-Y. Chou, F.-L. Chen, C.-C. Hu, C.-S. Chen, G.-Y. Lu, and C.-C. Yang
Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo
J. Antimicrob. Chemother., August 1, 2005; 56(2): 372 - 379.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
Y.-H. Li, P.-Z. Tao, Y.-Z. Liu, and J.-D. Jiang
Geldanamycin, a Ligand of Heat Shock Protein 90, Inhibits the Replication of Herpes Simplex Virus Type 1 In Vitro
Antimicrob. Agents Chemother., March 1, 2004; 48(3): 867 - 872.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J.-Y. Chang, C.-Y. Chang, C.-C. Kuo, L.-T. Chen, Y.-S. Wein, and Y.-H. Kuo
Salvinal, a Novel Microtubule Inhibitor Isolated from Salvia miltiorrhizae Bunge (Danshen), with Antimitotic Activity in Multidrug-Sensitive and -Resistant Human Tumor Cells
Mol. Pharmacol., January 1, 2004; 65(1): 77 - 84.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-D. Jiang, L. Denner, Y.-H. Ling, J.-N. Li, A. Davis, Y. Wang, Y. Li, J. Roboz, L.-G. Wang, R. Perez-Soler, et al.
Double Blockade of Cell Cycle at G1-S Transition and M Phase by 3-Iodoacetamido Benzoyl Ethyl Ester, a New Type of Tubulin Ligand
Cancer Res., November 1, 2002; 62(21): 6080 - 6088.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y.-H. Ling, J.-D. Jiang, J. F. Holland, and R. Perez-Soler
Arsenic Trioxide Produces Polymerization of Microtubules and Mitotic Arrest before Apoptosis in Human Tumor Cell Lines
Mol. Pharmacol., September 1, 2002; 62(3): 529 - 538.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.